Metastatic NSCLC - non-small cell lung cancer
Clinical trials for Metastatic NSCLC - non-small cell lung cancer explained in plain language.
Never miss a new study
Get alerted when new Metastatic NSCLC - non-small cell lung cancer trials appear
Sign up with your email to follow new studies for Metastatic NSCLC - non-small cell lung cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail targets Hard-to-Treat lung cancer
Disease control PausedThis phase 2 trial tests a combination of two drugs, olomorasib and pembrolizumab, as a first treatment for people with advanced non-small cell lung cancer that has a KRAS G12C mutation and a PD-L1 score between 1% and 49%. The main goal is to see how long patients live without t…
Matched conditions: METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER
Phase 2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New platform aims to predict lung cancer treatment success
Knowledge-focused OngoingThis study collects extra tissue samples from 200 people with advanced non-small cell lung cancer during routine biopsies. The goal is to train and validate a new diagnostic platform called Cybrid, which aims to predict how well a patient's tumor will respond to immunotherapy. Th…
Matched conditions: METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER
Sponsor: Elephas • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC